A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination cholesterol-lowering therapy sooner rather than later. By adding ezetimibe to statins within 12 weeks, patients lowered…
Beat the Clock: A Widely Available Pill Combo That Could Save Thousands of Hearts
